BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38910446)

  • 1. A patient with anti-f in India identified by extensive immunohematologic workup.
    Golia S; Pawar S; Tiwari AK; Aggarwal G; Singh N; Gupta S
    Immunohematology; 2024 Jun; 40(2):54-57. PubMed ID: 38910446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The routine use of Rh-negative reagent red cells for the identification of anti-D and the detection of non-D red cell antibodies.
    Shulman IA; Calderon C; Nelson JM; Nakayama R
    Transfusion; 1994 Aug; 34(8):666-70. PubMed ID: 8073481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.
    Thakral B; Saluja K; Sharma RR; Marwaha N
    Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On a much higher than reported incidence of anti-c in R1R1 patients with anti-E.
    Judd WJ; Dake LR; Davenport RD
    Immunohematology; 2005; 21(3):94-6. PubMed ID: 16178665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A red blood cell autoantibody with mimicking anti-E specificity.
    Dwyre DM; Clapper A; Heintz M; Elbert C; Strauss RG
    Transfusion; 2004 Sep; 44(9):1287-92. PubMed ID: 15318850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-f in a 24-year-old male: a case study.
    Jator EK; Pedde E
    Clin Lab Sci; 2010; 23(2):68-71. PubMed ID: 20499529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of monoclonal anti-Rh antibodies as reagents for blood grouping and for the identification of red cell membrane components associated with Rh antigen activity.
    Moore S; Green C; McGowan A
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):141-4. PubMed ID: 3145542
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of a gel microcolumn assay with the conventional tube test for red blood cell alloantibody titration.
    Finck R; Lui-Deguzman C; Teng SM; Davis R; Yuan S
    Transfusion; 2013 Apr; 53(4):811-5. PubMed ID: 22804101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
    Yee MEM; Josephson CD; Winkler AM; Webb J; Luban NLC; Leong T; Stowell SR; Fasano RM
    Transfusion; 2017 Nov; 57(11):2738-2746. PubMed ID: 28840600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density.
    Mota M; Fonseca NL; Rodrigues A; Kutner JM; Castilho L
    Vox Sang; 2005 Feb; 88(2):130-5. PubMed ID: 15720611
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-D alloimmunization in Rh(D) negative adults with severe traumatic injury.
    Raval JS; Madden KM; Neal MD; Moore SA
    Transfusion; 2021 Jul; 61 Suppl 1():S144-S149. PubMed ID: 34269429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Partial deletion of the D antigen in a family group. Determination of its antigenic density by flow cytometry].
    Hernández T; León G; Sánchez P
    Sangre (Barc); 1994 Apr; 39(2):139-43. PubMed ID: 7520193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloimmunization against platelets, granulocytes and erythrocytes in multi-transfused patients in Iranian population.
    Younesi MR; Louni Aligoudarzi S; Bigdeli R; Lashgari M; Mazaheri H; Asgary V
    Transfus Apher Sci; 2016 Oct; 55(2):205-211. PubMed ID: 27318433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alloimmunization to a high frequency Rh antigen].
    Cotorruelo C; Biondi C; Borras SG; Racca L; Brunetti D; Di Monaco R; Racca A
    Medicina (B Aires); 2006; 66(1):46-8. PubMed ID: 16555729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-Rho[D] antigen monoclonal antibodies. II. Serological characteristics of monoclonal IgG1 antibodies].
    Olovnikova NI; Belkina EV; Lemeneva LN; Berkovskiĭ AL; Deriugina EI; Chertkov IL
    Gematol Transfuziol; 1992; 37(9-10):5-9. PubMed ID: 1490578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-D alloimmunization propensity cannot be determined without information on D antigen exposure.
    Yazer MH; Triulzi DJ
    Transfusion; 2012 Sep; 52(9):2069-70; author reply 2070. PubMed ID: 22946977
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
    Ang AL; Lim CY; Ng WY; Lam JCM
    Transfusion; 2021 Sep; 61(9):2566-2577. PubMed ID: 34258773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system.
    Wilson B; Davison CL; Lopez GH; Millard GM; Liew YW; Powley T; Campbell T; Jadhao SS; Nagaraj SH; Perry M; Roulis EV; Toombs M; Irving DO; Flower RL; Hyland CA
    Transfusion; 2024 Jun; 64(6):1171-1176. PubMed ID: 38686705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of selected cells in immunohematology in a developing country: case studies.
    Dara RC; Tiwari AK; Arora D; Mitra S; Aggarwal G; Acharya DP; Bhardwaj G
    Immunohematology; 2017 Jan; 33(1):27-35. PubMed ID: 28425753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.